Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.

OBJECTIVES:Pharmacotherapy may have a limited role in long-term pain management. Comparative trajectories of drug prescriptions and costs, two quality-of-care indicators for pain conditions, are largely unknown subsequent to conventional or integrative care (IC) management. The objectives of this st...

Full description

Bibliographic Details
Main Authors: Tobias Sundberg, Max Petzold, Niko Kohls, Torkel Falkenberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4020818?pdf=render
id doaj-d22bd847fea245b0a362dc4a83f7cc5c
record_format Article
spelling doaj-d22bd847fea245b0a362dc4a83f7cc5c2020-11-25T01:56:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9671710.1371/journal.pone.0096717Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.Tobias SundbergMax PetzoldNiko KohlsTorkel FalkenbergOBJECTIVES:Pharmacotherapy may have a limited role in long-term pain management. Comparative trajectories of drug prescriptions and costs, two quality-of-care indicators for pain conditions, are largely unknown subsequent to conventional or integrative care (IC) management. The objectives of this study were to compare prescribed defined daily doses (DDD) and cost of first line drugs for pain patients referred to conventional or anthroposophic IC in Stockholm County, Sweden. METHODS:In this retrospective high quality registry case-control study, IC and conventional care patients were identified through inpatient care registries and matched on pain diagnosis (ICD-10: M79), age, gender and socio-demographics. National drug registry data was used to investigate changes in DDD and costs from 90/180 days before, to 90/180 days after, index visits to IC and conventional care. The primary selected drug category was analgesics, complemented by musculo-skeletal system drugs (e.g. anti-inflammatories, muscle relaxants) and psycholeptics (e.g. hypnotics, sedatives). RESULTS:After index care visits, conventional care pain patients (n = 1050) compared to IC patients (n = 213), were prescribed significantly more analgesics. The average (95% CI) group difference was 15.2 (6.0 to 24.3), p = 0.001, DDD/patient after 90 days; and 21.5 (7.4 to 35.6), p = 0.003, DDD/patient after 180 days. The cost of the prescribed and sold analgesics was significantly higher for conventional care after 90 days: euro/patient 10.7 (1.3 to 20.0), p = 0.025. Changes in drug prescription and costs for the other drug categories were not significantly different between groups. CONCLUSIONS:Drug prescriptions and costs of analgesics increased following conventional care and decreased following IC, indicating potentially fewer adverse drug events and beneficial societal cost savings with IC.http://europepmc.org/articles/PMC4020818?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Tobias Sundberg
Max Petzold
Niko Kohls
Torkel Falkenberg
spellingShingle Tobias Sundberg
Max Petzold
Niko Kohls
Torkel Falkenberg
Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.
PLoS ONE
author_facet Tobias Sundberg
Max Petzold
Niko Kohls
Torkel Falkenberg
author_sort Tobias Sundberg
title Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.
title_short Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.
title_full Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.
title_fullStr Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.
title_full_unstemmed Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.
title_sort opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description OBJECTIVES:Pharmacotherapy may have a limited role in long-term pain management. Comparative trajectories of drug prescriptions and costs, two quality-of-care indicators for pain conditions, are largely unknown subsequent to conventional or integrative care (IC) management. The objectives of this study were to compare prescribed defined daily doses (DDD) and cost of first line drugs for pain patients referred to conventional or anthroposophic IC in Stockholm County, Sweden. METHODS:In this retrospective high quality registry case-control study, IC and conventional care patients were identified through inpatient care registries and matched on pain diagnosis (ICD-10: M79), age, gender and socio-demographics. National drug registry data was used to investigate changes in DDD and costs from 90/180 days before, to 90/180 days after, index visits to IC and conventional care. The primary selected drug category was analgesics, complemented by musculo-skeletal system drugs (e.g. anti-inflammatories, muscle relaxants) and psycholeptics (e.g. hypnotics, sedatives). RESULTS:After index care visits, conventional care pain patients (n = 1050) compared to IC patients (n = 213), were prescribed significantly more analgesics. The average (95% CI) group difference was 15.2 (6.0 to 24.3), p = 0.001, DDD/patient after 90 days; and 21.5 (7.4 to 35.6), p = 0.003, DDD/patient after 180 days. The cost of the prescribed and sold analgesics was significantly higher for conventional care after 90 days: euro/patient 10.7 (1.3 to 20.0), p = 0.025. Changes in drug prescription and costs for the other drug categories were not significantly different between groups. CONCLUSIONS:Drug prescriptions and costs of analgesics increased following conventional care and decreased following IC, indicating potentially fewer adverse drug events and beneficial societal cost savings with IC.
url http://europepmc.org/articles/PMC4020818?pdf=render
work_keys_str_mv AT tobiassundberg oppositedrugprescriptionandcosttrajectoriesfollowingintegrativeandconventionalcareforpainacasecontrolstudy
AT maxpetzold oppositedrugprescriptionandcosttrajectoriesfollowingintegrativeandconventionalcareforpainacasecontrolstudy
AT nikokohls oppositedrugprescriptionandcosttrajectoriesfollowingintegrativeandconventionalcareforpainacasecontrolstudy
AT torkelfalkenberg oppositedrugprescriptionandcosttrajectoriesfollowingintegrativeandconventionalcareforpainacasecontrolstudy
_version_ 1724977412830134272